Press release
Antimicrobial Resistance Market Sets New Record, Projected at USD 9.5 Billion by 2032 | Innoviva, Inc., Pfizer Inc., Merck & Co., Inc., Acurx Pharmaceuticals.
Key Takeaways:
The combination therapies segment to maintain its leadership status throughout the forecast period
The Escherichia coli segment to maintain its lead position during the forecast period
The complicated urinary tract infections (cUTI) segment to maintain its lead position during the forecast period
North America to maintain its dominance by 2032.
Request Sample Copy of the Report:
https://www.alliedmarketresearch.com/request-sample/180698
What is the Impact of Recession 2023 on Antimicrobial Resistance Market?
The ongoing global recession had a significant effect on various industries including pharmaceutical and biotechnology industries. Reduced funding in sectors such as pharmaceuticals, biotechnology and chemicals has led to fluctuations in the development of novel antibiotics.
In addition, it has impacted purchasing decisions for costly medications, potentially affecting the adoption of novel antibiotics.
Major Factors Driving the Growth of Antimicrobial Resistance Market:
Increasing prevalence of antimicrobial resistance (AMR): AMR is a growing global health threat, with more and more bacteria becoming resistant to antibiotics. This is due to the overuse and misuse of antibiotics in humans and animals, as well as the poor spread of infection prevention and control measures.
Rising demand for new and innovative AMR diagnostics and treatments: As AMR becomes more widespread, there is a growing demand for new and innovative diagnostics and treatments to help identify and treat AMR infections. This is driving investment in the development of new AMR-targeted drugs, vaccines, and diagnostic tests.
Government support for AMR research and development: Governments around the world are providing support for AMR research and development in order to help combat this growing threat. This support is helping to fund the development of new AMR diagnostics and treatments, as well as to improve infection prevention and control measures.
Increasing awareness of AMR: Public awareness of AMR is growing, thanks to efforts by governments, healthcare organizations, and the media. This increased awareness is driving demand for AMR diagnostics and treatments, and is also helping to promote responsible antibiotic use.
Market Segmentation:
Product type:
Diagnostics: AMR diagnostics are used to identify the presence of AMR bacteria and to determine the antibiotic resistance profile of these bacteria. AMR diagnostics can be further segmented into:
Rapid diagnostic tests
Molecular diagnostics
Culture-based diagnostics
Therapeutics: AMR therapeutics are used to treat AMR infections. AMR therapeutics can be further segmented into:
Antibacterial drugs
Antivirals
Antifungals
Vaccines: AMR vaccines are used to prevent AMR infections. AMR vaccines are still under development, but there are a number of promising candidates in the pipeline.
Application:
Hospital settings: AMR diagnostics and therapeutics are widely used in hospital settings to diagnose and treat AMR infections.
Outpatient settings: AMR diagnostics and therapeutics are also used in outpatient settings, such as clinics and doctor's offices.
Community settings: AMR diagnostics and therapeutics are increasingly being used in community settings, such as schools and workplaces, to prevent and treat AMR infections.
End user:
Hospitals: Hospitals are the largest users of AMR diagnostics and therapeutics.
Clinical laboratories: Clinical laboratories also use AMR diagnostics to diagnose AMR infections.
Pharmacies: Pharmacies dispense AMR therapeutics to patients.
Other end users: Other end users of AMR diagnostics and therapeutics include governments, public health organizations, and non-profit organizations.
Geography:
North America: North America is the largest market for AMR diagnostics and therapeutics.
Europe: Europe is the second-largest market for AMR diagnostics and therapeutics.
Asia Pacific: Asia Pacific is the fastest-growing market for AMR diagnostics and therapeutics.
Request for Customization:
https://www.alliedmarketresearch.com/request-for-customization/180698
Regional Growth Dynamics:
Based on region, North America held the highest market share in terms of revenue in 2022, accounting for nearly three-fifths of the global antimicrobial resistance market revenue. North America is witnessing notable growth trends, owing to its well-developed healthcare industry and easy availability of advanced medical solutions.
Competitive Landscape:
Alkem Laboratories Ltd.
Pfizer Inc.
Acurx Pharmaceuticals, Inc.
Basilea Pharmaceutica Ltd
Cumberland Pharmaceuticals
Wockhardt Limited.
Paratek Pharmaceuticals Inc
Nabriva Therapeutics Plc
Innoviva, Inc
Merck And Co., Inc.
Recent developments:
New rapid diagnostic tests are being used in hospitals and emergency rooms to help doctors to prescribe the most effective antibiotics more quickly and accurately.
New antibacterial drugs are being used to treat AMR infections caused by bacteria such as Staphylococcus aureus and Acinetobacter baumannii.
New antivirals and antifungals are being used to treat AMR infections caused by viruses and fungi such as HIV and Candida auris.
New AMR vaccines are being tested in clinical trials, and some of these vaccines are expected to be approved for use in the next few years.
Buy this Premium Research Report:
https://www.alliedmarketresearch.com/purchase-enquiry/180698
Comprehensive Healthcare Industry Research Studies:
Clinical Trial Imaging Services Market https://www.alliedmarketresearch.com/clinical-trial-imaging-services-market-A09463
Contraceptive Drugs Market https://www.alliedmarketresearch.com/contraceptive-drugs-market-A09485
Dialysis Market https://www.alliedmarketresearch.com/dialysis-market
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antimicrobial Resistance Market Sets New Record, Projected at USD 9.5 Billion by 2032 | Innoviva, Inc., Pfizer Inc., Merck & Co., Inc., Acurx Pharmaceuticals. here
News-ID: 3383698 • Views: …
More Releases from Allied Market Research
Global Urinary Drainage Bags Market: Trends, Growth, and Insights to 2031
The global urinary drainage bags market is experiencing robust growth, with its market size valued at $1.4billion in 2021 and projected to reach $2billion by 2031. This expansion represents a compound annual growth rate (CAGR) of 3.8% from 2021 to 2031, highlighting the increasing demand for these essential medical devices.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A17529
What Are Urinary Drainage Bags?
Urinary drainage bags are specialized medical devices designed to collect…
Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…
Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…
Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…
More Releases for AMR
The 73rd AMR China International Auto Parts Exhibition
Exhibition Introduction
With the further recovery of the economy, consumer confidence has been boosted and gradually restored. China's automobile industry has shown strong resilience in the ever-changing market environment and ushered in an important period of opportunity for transformation, upgrading and high-quality development.
As a highly influential automotive aftermarket industry event in northern China, especially in the Beijing-Tianjin-Hebei region, the AMR China International Automotive Maintenance, Inspection and Diagnosis Equipment, Parts and Beauty…
Yeast Ingredients Market Booming $6.6Bn by 2032 | AMR
According to a new report published by Allied Market Research, titled, "Yeast Ingredients Market," The yeast ingredients market was valued at $2.9 billion in 2022, and is estimated to reach $6.6 billion by 2032, growing at a CAGR of 8.8% from 2023 to 2032.
𝐀𝐜𝐜𝐞𝐬𝐬 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://www.alliedmarketresearch.com/request-sample/A323211
Yeast ingredients find extensive applications across diverse sectors including food & beverage, pharmaceuticals, and animal feed owing to their multifaceted properties. Despite…
Sustainability LIVE Dubai: Amr Kandil, Schneider Electric
Amr Kandil, MEA Director of Real Estate segment and New Energy Landscape at Schneider Electric to speak at Sustainability LIVE Dubai - 15 May 2024
Connecting the world's sustainability leaders, Sustainability LIVE will be returning in 2024 to bring the biggest global businesses together to deliver insightful keynotes, fireside chats, and panel discussions sharing valuable knowledge and real-world experiences.
The ultimate virtual event for sustainability and ESG leaders in the Middle East…
AGV & AMR in Logistics Market Automated Guided Vehicles (AGV) and Autonomous Mob …
The Report on "AGV & AMR in Logistics Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of AGV & AMR in Logistics Market: The AGV & AMR in Logistics market is experiencing robust growth driven by the increasing need for automated and efficient material handling in logistics and warehousing. Market…
The Growing Importance of the Cephalosporin Market | By AMR
Allied Market Research recently said Cephalosporins are a group of antibiotics that have been widely used in the medical industry for over 50 years. They were first discovered in 1945 by Dr. Giuseppe Brotzu, an Italian scientist, and were initially used to treat staphylococcal infections. Today, cephalosporins are used to treat a wide range of bacterial infections and are considered one of the most important classes of antibiotics.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞…
UGV Adoptions boost Global Autonomous Mobile Robots (AMR) Market
Inkwood Research expects the Global Autonomous Mobile Robots (AMR) Market to surge with a 21.31% CAGR during the forecast years between 2022 and 2030, generating $14473.73 million in revenue by 2030.
Browse 45 market Data Tables and 43 Figures spread over 224 Pages, along with an in-depth analysis of the Global Autonomous Mobile Robots (AMR) Market by Robot Type, End-User, & Geography.
This insightful market research report by Inkwood Research focuses on…
